Future Growth Opportunities in Generics: The Impact of Consolidation on Market and Competitive Dynamics.LYON, France -- Allbizreport.com announces that a new market research report related to the world wide Generics Pharmaceutical market is now available to its catalogue. Future Growth Opportunities in Generics (www.allbizreport.com/Future-Growth-Opportunities-in-Generics.html) The number of commercially lucrative drugs coming off patent has catalyzed the growth of the generics industry, creating significant profit opportunities for generics manufacturers. However, this market faces a considerable number of threats, with bulk manufacturers from developing countries becoming internationally competitive and the aggressive actions of branded pharmaceutical marketers in protecting their patent and market position resulting in ramifications ramifications npl → Auswirkungen pl for the sector as a whole.Future Growth Opportunities in Generics provides an in-depth analysis into the direction of the global generics market, evaluating competitive dynamics through a detailed review of major consolidation activity in the sector. Opportunities for future success are also explored, including the potential offered by biosimilars and the increasing focus by governments on healthcare cost containment cost containment, n the features of a dental benefits program or of the administration of the program designed to reduce or eliminate certain charges to the plan. , enabling you to determine the factors crucial to your success in the global generics market. Key findings of the report... * The global unbranded generics market was valued at $38bn in 2005, up 14.3% on 2004 sales of $33bn. The generics market has witnessed strong growth over the previous five years and has more than doubled in size since 2001. * Although, historically the US market has enjoyed a higher rate of popularity for new generic entrants, due to increased competition, companies now tend to look into expanding into markets with developing growth potential, such as the under-penetrated markets of the EU and the emerging markets in Asia. * M&A continues to be a main strategy for growth as generics companies continue to vie to enhance their portfolio status, undertake geographic expansion or to gain monopoly in a particular region or therapeutic area, with price pressures and technology access being the key pressures driving acquisition activity. * The generics market appears poised for future growth, with upcoming expiries of blockbuster block·bust·er n. 1. Something, such as a film or book, that sustains widespread popularity and achieves enormous sales. 2. A high-explosive bomb used for demolition purposes. 3. products forecast to further fuel growth particularly in hormonal hormonal, adj/n beneficial component in some essential oils that helps to bring hormone secretions to normal levels. hormonal emanating from or pertaining to hormones. cancers, hypertension hypertension or high blood pressure, elevated blood pressure resulting from an increase in the amount of blood pumped by the heart or from increased resistance to the flow of blood through the small arterial blood vessels (arterioles). , dyslipidemia, bacterial bacterial /bac·te·ri·al/ (-al) pertaining to or caused by bacteria. bacterial pertaining to or caused by bacteria. bacterial adhesiveness see adhesins. infections, viral infections viral infection, n an infection by a pathogenic virus. A virus acts on the cell nucleus, taking over the genetic material within the nucleus and replicating itself. , schizophrenia schizophrenia (skĭt'səfrē`nēə), group of severe mental disorders characterized by reality distortions resulting in unusual thought patterns and behaviors. and epilepsy epilepsy, a chronic disorder of cerebral function characterized by periodic convulsive seizures. There are many conditions that have epileptic seizures. Sudden discharge of excess electrical activity, which can be either generalized (involving many areas of cells in indications.Key questions answered in this report * What key strategies are generic companies utilizing in order to increase their market share and ensure healthy profit margins? * Which country markets will see the highest growth and what are the most attractive therapy areas for generics companies to target? * What are the current generic market trends within the major therapy areas of cardiovascular, cancer, gastrointestinal gastrointestinal /gas·tro·in·tes·ti·nal/ (-in-tes´ti-n'l) pertaining to or communicating with the stomach and intestine. gas·tro·in·tes·ti·nal adj. Abbr. , anti-infectives and CNS See Continuous net settlement. CNS See continuous net settlement (CNS). ? * What is the extent of the threat on branded products from the growth of the global generics market? * How do branded pharmaceutical companies defend against the threat of generics competition? * Which companies are best positioned to succeed in biosimilars?Top five reasons to order your copy today * Identify the therapeutic areas with the most potential for generic growth and ensure your portfolio is aligned with future market opportunity. * Understand how geographic expansion is one of the major reasons behind recent consolidation in the industry, and evaluate which national markets are poised for growth over the next 5 years. * Evaluate how the market shares of the leading generics companies, such as Novartis, Teva and Mylan will change over the next 5 years, and assess your competitive position within the market. * Discover what key strategies generics companies are utilizing in order to increase market share and achieve a competitive advantage. * Assess the defensive strategies implemented by branded pharmaceutical marketers to protect their patents and delay generic entry, and understand how this affects the generics market place. Key players profiled such as : Novartis, Teva, Mylan, Ratiopharm, Watson, Merck KGaA This article needs sources or references that appear in reliable, third-party publications. Alone, primary sources and sources affiliated with the subject of this article are not sufficient for an accurate encyclopedia article. , Ivax, Apotex, Par, Alpharma, Dr. Reddy's, Betapharm, Roche, Trigenesis, Ranbaxy, Mundoge, Ethimed, Terapia, Egis, Serdix, Zentiva, Sicomed , Sandoz / Novartis, Sabex, Hexal / Eon acquisition, Stada Arzneimittel, Hemofarm, Nizpharm , Magnafarma BV, Pulmotec, Ribosepharm, Prasfarma acquisition, NM Pharma, Actavis, Amide, Sindan , Keri Pharma, Amarin, Sekhsaria, Andrx, Barr, Pliva, Matrix Labs, Perrigo, Agis More market research reports ? Go to http://www.allbizreport.com |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion